Ovarian cancer carries a specific set of risk factors, from environmental causes to hereditary traits, and the key to decreasing mortality rates is early detection. For example, half of all ovarian cancers occur in women older than 63 years of age, while women who have used oral contraceptives have a lower risk of developing epithelial ovarian … Continued
Dr. Charanjeev Kapoor of RCCA’s Connecticut Division Cancer that begins in the testicles is known as testicular cancer. According to Dr. Charanjeev Kapoor, an oncology specialist at Regional Cancer Care Associates (RCCA), the key to diagnosing and treating testicular cancer is patient awareness. Affecting only about 1 in every 263 men in the United States, testicular cancer … Continued
Dr. Joseph McLaughlin If you’ve never smoked or used tobacco, could you still be susceptible to lung cancer? The short answer is yes. According to the ACS, up to 20% of patients who die from lung cancer are non-smokers. Oncology specialist, Dr. Joseph McLaughlin – from the Regional Cancer Care Associates (RCCA) Manchester, Connecticut location … Continued
Gurpreet S. Lamba, MD What are the main types of leukemia? How do they differ in terms of their effects, how they present and how they are treated? A. Leukemia is classified based on whether the malignancy originated from a lymphoid or myeloid white blood cell, and on how quickly the leukemia develops (i.e., … Continued
Dr. Joel Silver How do myeloma and chronic lymphocytic leukemia (CLL) develop? What are some risk factors associated with those malignancies? A. We don’t know what causes CLL. We do know that people in some occupations or with a certain exposure history might be at higher risk, and that CLL generally affects older people. … Continued
As the third most common cancer in the United States, colorectal cancer (CRC) affects about 1 in 20 Americans. However, incidence and death rates for cancer of the colorectum have significantly decreased over the past several decades as a result of increased screening and drastic improvements in treatment. In Maryland alone, approximately 70% of adults … Continued
Phillip D. Reid, MD What is molecular testing? How it is used in cancer care? A. As we learn how to treat specific subtypes of cancer more accurately, molecular testing, molecular medicine and molecular diagnostics are becoming more prominent in oncology. In the past, once a cancer was diagnosed, we determined the organ where … Continued
Ralph V. Boccia, MD, a cancer specialist at RCCA Maryland, provides some insight into recent colorectal cancer trends and treatments that are giving new hope to doctors, researchers and patients nationwide. Overall, Dr. Boccia finds much to be encouraged by, but also points to the need for awareness of a concerning development in the field … Continued
[Hackensack, NJ] – RCCA is proud to announce that it has earned URAC accreditation in Specialty Pharmacy. URAC is the independent leader in promoting healthcare quality through accreditation, certification and measurement. By achieving this status, RCCA has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes. “URAC Accreditation is a … Continued
HACKENSACK, N.J., Nov. 22, 2016 /PRNewswire-USNewswire/ — Regional Cancer Care Associates (RCCA) is expanding its cancer care payment initiative with UnitedHealthcare to RCCA patients in Maryland who are covered by UnitedHealthcare benefit plans. The program, made available at RCCA New Jersey locations in January, rewards physicians for focusing on best treatment practices, quality patient care and … Continued